Skip to main content

Oligonucleotides and Oligonucleotide Conjugates: A New Approach for Cancer Treatment

Buy Article:

$63.00 plus tax (Refund Policy)


In this account we summarise recent studies on oligonucleotides and oligonucleotide derivatives and their utilisation in antigene, antisense and decoy approaches, with particular attention to peptide nucleic acids, locked nucleic acids and oligonucleotide conjugates, the most promising compounds in this field.

Keywords: Rnase; antisense oligonucleotides; gene-directed therapy; hybridisation; mrna

Document Type: Review Article


Affiliations: Dipartimento di Scienze Farmaceutiche, Universita di Trieste, Piazzale Europa.

Publication date: January 1, 2005

More about this publication?
  • Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more